Deleterious Effects of β-Blockers on Exercise Capacity and Hemodynamics in Patients With Portopulmonary Hypertension
Authors:
- Steeve ProvencherSPSteeve Provencher
- Philippe HervePHPhilippe Herve
- Xavier JaisXJXavier Jais
- Didier LebrecDLDidier Lebrec
- Marc HumbertMHMarc Humbert
- Gerald SimonneauGSGerald Simonneau
- Olivier SitbonOSOlivier Sitbon
- 1 January 2006
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 130 (1) , 120-126
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Pulmonary–Hepatic vascular Disorders (PHD)European Respiratory Journal, 2004
- Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertensionJACC, 2004
- Diagnosis and differential assessment of pulmonary arterial hypertensionJACC, 2004
- Clinical classification of pulmonary hypertensionJACC, 2004
- Haemodynamic evaluation of pulmonary hypertensionEuropean Respiratory Journal, 2002
- ATS Statement: Guidelines for the Six-Minute Walk TestAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Pulmonary Artery Pressure–Flow Relations after Prostacyclin in Primary Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2002
- 7 Haemodynamic assessmentBailliere's Clinical Gastroenterology, 1995
- Inhaled Nitric Oxide as a Screening Vasodilator Agent in Primary Pulmonary Hypertension. A Dose-Response Study and Comparison with ProstacyclinAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Beta-Adrenergic–Antagonist Drugs in the Prevention of Gastrointestinal Bleeding in Patients with Cirrhosis and Esophageal VaricesNew England Journal of Medicine, 1991